Talling, Sitti Nurhata .

HRN: 23-33-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2024
AMPICILLIN 1GM (VIAL)
03/03/2024
03/03/2024
IV
2g
Q6hrs
PROM X 3 HOURS, GROSSLY LEAKING BOW
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: